Compass Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Revolution Medicines Inc. Common Stock trades at $188.5 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 5.7× Compass Inc. Class A Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Compass Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| COMP | RVMD | |
|---|---|---|
Market Cap | $7.05B | $40.32B |
Volume | 15,310,192 | 4,855,734 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $221.15 |
52-Week Low | $6.68 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.47B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →